Accounting for the drug life cycle and future drug prices in cost-effectiveness analysis.

Accounting for the drug life cycle and future drug prices in cost-effectiveness analysis.

Item
http://www.wikidata.org/entity/Q39808042
Multicohort models in cost-effectiveness analysis: why aggregating estimates over multiple cohorts can hide useful informationThe value of innovation under value-based pricing.Cinacalcet: a pharmacoeconomic review of its use in secondary hyperparathyroidism in end-stage renal disease.Cost-effectiveness of natalizumab in multiple sclerosis: an updated systematic review.New Zealand's drug development industry.Are the UK systems of innovation and evaluation of medical devices compatible? The role of NICE's Medical Technologies Evaluation Programme (MTEP).Emergent Challenges in Determining Costs for Economic Evaluations.The determinants of cost-effectiveness potential: an historical perspective on lipid-lowering therapies.Systematic overview of cost-effectiveness thresholds in ten countries across four continents.Valuing Trial Designs from a Pharmaceutical Perspective Using Value-Based Pricing.The importance of model inputs and assumptions in conducting health technology assessments of novel drugs.Cost-effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia in older adults without deletion 17p
P2860

Accounting for the drug life cycle and future drug prices in cost-effectiveness analysis.

Item
http://www.wikidata.org/entity/Q39808042
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Accounting for the drug life cycle and future drug prices in cost-effectiveness analysis.
@en
Accounting for the drug life cycle and future drug prices in cost-effectiveness analysis.
@nl
type
label
Accounting for the drug life cycle and future drug prices in cost-effectiveness analysis.
@en
Accounting for the drug life cycle and future drug prices in cost-effectiveness analysis.
@nl
prefLabel
Accounting for the drug life cycle and future drug prices in cost-effectiveness analysis.
@en
Accounting for the drug life cycle and future drug prices in cost-effectiveness analysis.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P356
P1433
P1476
Accounting for the drug life cycle and future drug prices in cost-effectiveness analysis.
@en
P2093
P2860
P2888
P304
P31
P356
10.2165/11584230-000000000-00000
P433
P478
P577
P5875
P6179
P698